Acquired Infections Testing Market Size, Share, Competitive Landscape and Trend Analysis Report by Sources, by Types, by Testing Method, by End-users and by Applications : Opportunity Analysis and Industry Forecast, 2023-2032

The report provides a detailed analysis of the Acquired infections testing market on the global and regional level. The study further offers insights based on the key determinants of the market, including drivers and challenges along with their relative impact on the global, regional, and country levels. In addition, the report examines the potential opportunities for the players to enter the Acquired infections testing market.

The report describes competitive landscape of the major market players to boost their shares and remain competitive in the industry. The study includes Porter’s five forces model and PESTEL analysis to understand the competitive scenario of the industry. The study covers the top investment pockets for investor to capitalize in the approaching time. These analysis frameworks are benchmarked on the basis of their relative market share, CAGR, and market attractiveness. The competition section of the report provides comprehensive assessment on company offering financials, business strategies, and developments. The section further contains data on regional penetration of local companies in the market along with their relative market share globally.

The company profiles in the report cover strategic developments such as acquisitions & mergers, agreements, partnerships, product/service launch, collaborations, joint ventures, research & development investment, and regional expansion of major companies in the market at global and regional level.

Key players identified in this report are Danaher Corporation, Roche Holding AG, Abbott Laboratories, Illumina, Inc., Agilent Technologies, Inc., QIAGEN, Beckman Coulter, Inc., BioMérieux SA, Lyra Laboratory Solutions, Thermo Fisher Scientific, Inc.

  Acquired Infections Testing Market Report Highlights

Aspects	Details
By Sources	Hospital-Acquired Infection (HAI) Community-Acquired Infection (CAI) Medical Technology-Associated Infection
By Types	Bacterial Infection Viral Infection Fungal Infection
By Testing Method	Molecular Testing Microbiology Lab Testing Immunoassay Testing
By End-users	Hospitals Clinical Laboratories Academic and Research Institutes
By Applications	Identification Testing Laboratory Testing Bedside Hospital Testing
By Region	North America  (U.S., Canada, Mexico) Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe) Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific) LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
Key Market Players	Lyra Laboratory Solutions, QIAGEN, Thermo Fisher Scientific, Abbott Laboratories, Roche Holding AG, Illumina, Agilent Technologies, Beckman Coulter, BioMérieux SA, Danaher Corporation

^*Terms and Conditions Apply